Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;177(2):437-43.
doi: 10.1016/j.juro.2006.09.027.

Defining optimal therapy for muscle invasive bladder cancer

Harry W Herr  1 , Zohar Dotan, S Machele Donat, Dean F Bajorin
Affiliations
Review

Defining optimal therapy for muscle invasive bladder cancer

Harry W Herr et al. J Urol. 2007 Feb.

Abstract

Purpose: We defined an optimal curative strategy for muscle invasive bladder cancer and to determine how best to deliver curative therapy.

Materials and methods: We reviewed published reports from 1985 to 2006 dealing with the treatment of muscle invasive (stage T2-T4a) bladder cancer. We analyzed all cohort, phase II and randomized phase III studies providing level 1 to 3 evidence impacting survival.

Results: Cisplatin based chemotherapy combined with high quality radical cystectomy and complete pelvic lymph node dissection improves survival over that of cystectomy alone. Surgery quality is an important predictor of survival even in patients receiving chemotherapy. Neoadjuvant chemotherapy is favored over adjuvant chemotherapy because it is better tolerated and more patients are able to receive effective therapy before rather than after surgery.

Conclusions: Neoadjuvant chemotherapy followed by radical cystectomy and complete pelvic lymph node dissection is the optimal curative strategy in most patients presenting with muscle invasive bladder cancer.

PubMed Disclaimer

Comment in